Valuation: Shockwave Medical

Market Cap 12.57B 11.09B 10.49B 9.52B 17.84B 1,206B 18.02B 126B 48.52B 616B 47.19B 46.16B 1,982B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 12.35B 10.9B 10.31B 9.35B 17.53B 1,185B 17.7B 124B 47.67B 605B 46.37B 45.36B 1,947B EV / Sales 2025 *
-
EV / Sales 2026 * -
Free-Float
-
Yield 2025 *
-
Yield 2026 * -
1 day-0.01%
1 week+0.01%
Current month+0.01%
1 month+0.01%
3 months+0.01%
6 months+0.01%
Current year+0.01%
3 years 157
Extreme 157
334.9
5 years 113.36
Extreme 113.36
334.9
10 years 22.01
Extreme 22.01
334.9
Manager TitleAgeSince
Director of Finance/CFO 48 30/05/2024
President 51 31/10/2018
Chief Tech/Sci/R&D Officer 58 -
Director TitleAgeSince
Director/Board Member - 30/05/2024
Director/Board Member - 30/05/2024
Director/Board Member - 30/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
31/05/24 Issuer sale

Director

106,226 0.2833%
31/05/24
Sofinnova Partners SAS
Issuer saleCompany 34,177 0.0911%
31/05/24 Issuer sale

Director

33,969 0.0906%
Change 5-day change 1-year change 3-year change Capi.($)
-0.01%+0.01%+0.01%+68.15% 12.57B
-0.10%-0.17%+26.71%+31.81% 12.56B
+0.34%+0.94%+22.52%+30.96% 6.72B
-2.20%-5.47% - - 5.64B
-0.15%-0.39%+38.46%+27.71% 5.6B
-0.76%-1.39%-23.42%+31.82% 4.98B
-2.51%-3.39%-33.51%-25.46% 3.81B
+1.01%-4.08%+23.76%-0.99% 1.86B
+7.77%+20.85%+9.44%+230.37% 1.86B
-0.34%-5.23%+41.60%-15.08% 1.51B
Average +0.30%-0.26%+11.73%+42.14% 5.71B
Weighted average by Cap. -0.17%-0.48%+11.32%+40.49%

Financials

2025 *2026 *
Net sales - -
Net income - -
Net Debt - -
Logo Shockwave Medical
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
Employees
1,468
  1. Stock Market
  2. Stocks
  3. SWAV Stock